Table 1.
Baseline demographics of the study population
| Total(n = 42) | Cyclosporin(n = 32) | Tacrolimus(n = 10) | P-value | |
|---|---|---|---|---|
| Demographics | ||||
| Age (years) | 44.3 ± 13.1 | 46.9 ± 12.7 | 35.5 ± 10.2 | 0.02 |
| Caucasian | 41 (98%) | 31 (97%) | 10 (100%) | 0.89 |
| Male sex | 24 (57%) | 20 (63%) | 4 (40%) | 0.29 |
| Body weight (kg) | 72.9 ± 14.8 | 74.3 ± 15.2 | 68.6 ± 13.4 | 0.29 |
| BMI (kg m−2) | 25.3 ± 3.9 | 25.7 ± 3.9 | 24.1 ± 3.8 | 0.26 |
| Diabetes | 5 (12%) | 4 (10%) | 1 (10%) | 0.92 |
| CAPD pretransplant | 14 (33%) | 12 (38%) | 2 (20%) | 0.41 |
| Cadaveric donor | 29 (69%) | 24 (75%) | 5 (50%) | 0.24 |
| First transplant | 37 (88%) | 31 (97%) | 6 (60%) | 0.08 |
| HLA mismatch | 3 [2–5] | 3 [2–5] | [2–4] | 0.86 |
| Peak PRA | 0 [0–2] | 0 [0–2] | 0 [0–2] | 0.94 |
| Ischaemic time (h) | 8.7 ± 5.9 | 9.5 ± 5.9 | 6.1 ± 5.2 | 0.11 |
| Creatinine (mmol l−1) | 0.16 [0.11–0.26] | 0.16 [0.11–0.23] | 0.14 [0.11–0.35] | 0.85 |
| CC (ml min−1) | 40.1 ± 22.0 | 39.8 ± 19.4 | 41.0 ± 30.1 | 0.89 |
| Delayed graft function | 4 (10%) | 3 (9%) | 1 (10%) | 0.99 |
Results are expressed as mean ±SD, median [IQR] or frequency (percentage), depending on data type. BMI, Body mass index; CAPD, continuous ambulatory peritoneal dialysis; HLA, haplotype mismatch; PRA, panel reactive bodies; CC, creatinine clearance. Delayed graft function is defined as the need for dialysis post-transplant.